EX PARTE APPEAL PENDING
on 20 Dec 2024
Last Applicant/ Owned by
Medawar Centre, 2nd Floor East Building, Robert Robinson Avenue Oxford, Oxfordshire OX4 4HG
Serial Number
79359336 filed on 01st Dec 2022
Registration Number
N/A
Correspondent Address
NANCY SABARRA
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
EVOX THERAPEUTICS
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services, including those in the field of pharmaceuticals; biological research; clinical research, including in the field of transformational therapeutics; providing medical and scientific research informa Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; laboratory analysis service relating to the diagnosis and treatment of persons, including medical laboratory analysis service relating to the diagnosis and treatment of persons; medical analysis and examinations; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of viral and bacterial based infections and diseases, including medical services such as medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of viral and bacterial based infections and diseases; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies, including mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services, including those in the field of pharmaceuticals; biological research; clinical research, including in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood, including providing medical research information and scientific research information all in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceuticals, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations and substances, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for therapeutic use, including those that facilitate the delivery of pharmaceutical preparations for therapeutic use; pharmaceutical preparations, namely, exosomes to deliver protein for genetic therapy, including those that facilitate the delivery of pharmaceutical preparations; medicine, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; medical preparations and articles, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations for medical purposes, including for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological preparations for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies, including mitochondrial disease, joint and ligament strains and tears, muscle atrophy, muscular dystrophy; biological preparations comprising exosome, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations comprising a therapeutic target protein-loaded exosome, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations comprising exosome for pharmaceutical purposes, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological reagents for medical use, including drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; mixed biological preparations for medical purposes, including for the prevention and treatment of infectious diseases; mixed biological preparations for the prevention and treatment of infectious diseases; diagnostic reagents used in the fields of biological, genetic engineering and pharmaceutical research; diagnostic reagents comprising exosome used in the fields of biological, genetic engineering and pharmaceutical research; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle (EV)-based nucleic acid therapeutics for the prevention and treatment of infections or disease, including infectious diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies, including including mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79359336
Mark Type
No Service Mark
Attorney Docket Number
No EVOX 2312584
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Dec 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| 20th Dec 2024 | EX PARTE APPEAL-INSTITUTED |
| 20th Dec 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| 20th Dec 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 25th Nov 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 20th Jun 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 20th Jun 2024 | FINAL REFUSAL E-MAILED |
| 20th Jun 2024 | FINAL REFUSAL WRITTEN |
| 07th Jun 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 14th May 2024 | ASSIGNED TO EXAMINER |